#APLAR22

Speakers

We are pleased to announce the below plenary and invited speakers for APLAR 2022. 

Browse through their profiles, by clicking on their photo for more information. 

New speakers are always being confirmed, so be sure to check back regularly for new additions!

Prof. Peter Nash
Griffith University, Queensland, Australia
Prof. James Wei
Institute of Medicine, Chung Shan Medical University, Taiwan
Prof. Debashish Danda
India
Prof. Annamaria Iagnocco
The University Of Turin, Italy
Prof. Iain McInnes
United Kingdom
Prof. Eric Morand
Monash University School Of Clinical Sciences, Australia
Prof. Ranjeny Thomas
University of Queensland, Australia
Prof. Kenneth Saag
University Of Alabama At Birmingham, United States
Prof. Dr. Georg Schett
Universitätsklinikum Erlangen, Department of Medicine 3, Germany
Prof. Tsutomu Takeuchi
Japan
Prof. Lai-Shan Tam
The Chinese University Of Hong Kong, Hong Kong
Dr. Sakir Ahmed
Kalinga Institute Of Medical Sicences, India
Prof. Sulaiman Al-Mayouf
King Faisal Specialist Hospital & Research Center, Saudi Arabia
Dr. Elizabeth Ang
National University Hospital, Singapore
A/Prof. Thaschawee Arkachaisri
Kk Women's And Children's Hospital, Duke-nus Medical School, Singapore
Prof. Tatsuya Atsumi
Hokkaido University, Japan
Dr. Sunith Himantha Atukorale
Ministry Of Health, Sri Lanka
Dr. Elaine Au
Queen Mary Hospital, Hong Kong
A/Prof. Christine Bernal
University Of Santo Tomas, Philippines
Prof. Andrew Briggs
Curtin University, Australia
Matthew Buckland
UCL GOSH-ICH, United Kingdom
Dr. Cynthia Chan
Pamela Youde Nethersole Eastern Hospital, Hong Kong
Prof. T M Chan
University of Hong Kong, Hong Kong
Dr. Shirley Chiu Wai Chan
University Of Hong Kong, Hong Kong
Sze Ngai Jeffrey Chau
Grappa Prp, Hong Kong
Xanthe Chua
TAn Tock Seng Hospital, Singapore
Assoc. Prof. Sumapa Chaiamnuay
Phramongkutklao Hospital, Thailand
Prof. Ernest Choy
Cardiff University School of Medicine, United Kingdom
Dr Ho Yin Chung
Hong Kong Society Of Rheumatology, Hong Kong
Prof. Francesco Ciccia
University Della Campania L. Vanvitelli, Italy
Prof. Debashish Danda
India
Dr. Thorlene Egerton
The University Of Melbourne, Australia
Prof. Dirk Elewaut
Vib Center For Inflammation Research; Ghent University, Belgium
Dr. Ivan Foeldvari
Hamburger Zentrum Für Kinder- Und Jugendrheumatologie, Germany
Prof. Sumaira Farman
National Hospital & Medical Center; Central Park Medical College; FJMU; Arthritis Care Foundation, Pakistan
Dr. Shunsuke Furuta
Chiba University Hospital, Japan
Dr Takahisa Gono
Department Of Allergy And Rheumatology, Nippon Medical School Graduate School Of Medicine, Japan
Dr. Jon Giles
Columbia University, Vagelos College Of Physicians & Surgeons, United States
Latika Gupta
India
Prof. Rebecca Grainger
University of Otago, New Zealand
Sofia Grigoriadou
Barts Health Nhs Trust, United Kingdom
Dr. Laniyati Hamijoyo
University Of Padjadjaran, Indonesia
Muhammad Haroon
Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Pakistan
Prof. Masayoshi Harigai
Tokyo Women's Medical University, Japan
Dr. Tze Kwan, Carmen Ho
Queen Mary Hospital, Hong Kong
Prof. Annamaria Iagnocco
The University Of Turin, Italy
Dr. Kei Ikeda
Chiba University Hospital
Dr. Kanon Jatuworapruk
Thammasat University, Thailand
Dr. Matthew Jiang
Western Health, Australia
Prof. Alireza Khabbazi
Connective Tissue Diseases Research Center, Tabriz University Of Medical Sciences, Tabriz, Iran
Dinesh Khanna
University of Michigan, United States
Prof. Masataka Kuwana
Nippon Medical School, Japan
Prof. Mitsumasa Kishimoto
Kyorin university school of medicine, Japan
Ms Kwok Suet Kei
Hospital Authority, Hong Kong
A/Prof. Yohei Kirino
Yokohama City University, Japan
Dr. Laura Lewandowski
Head, Lupus Genomics and Global Disparities Unit, NIAMS, NIH, United States
Dr. Philip Li
The University of Hong Kong, Hong Kong
Prof. Worawit Louthrenoo
Thailand
Dr. Kuo-Lung Lai
Division Of Allergy, Immunology And Rheumatology, Department Of Internal Medicine, Taichung Veterans General Hospital, Taiwan
Prof. Chak-Sing Lau
The University of Hong Kong, Hong Kong
Dr. Vince Lau
Gleneagles Hospital, Hong Kong
Dr. Ka Wing Gavin Lee
Hong Kong Sanatorium & Hospital, Hong Kong
Dr. Victor Lee
CUHK Medical Centre, Hong Kong
Katy Leung
Singapore General Hospital, Singapore
Prof. Vidya Limaye
Royal Adelaide Hospital, Australia
Prof. Liwei Lu
The University of Hong Kong, Hong Kong
Prof. Ingrid Lundberg
Karolinska Institutet, Sweden
Assoc. Prof. Dr. PhD Peter Mandl
Division Of Rheumatology, Medical University Of Vienna, Austria
Prof Ashish Jacob Matthew
Christian Medical College, Vellore, India
Prof. Iain McInnes
United Kingdom
A/Prof. Takako Miyamae
Tokyo Women's Medical University, Japan
Chi Chiu Mok
Tuen Mun Hospital, Hong Kong
Prof. Ingrid Moller
Instituto Poal De Reumatologia Barcelona, University Of Barcelona International University Of Catalunya, Spain
Prof. Eric Morand
Monash University School Of Clinical Sciences, Australia
Kathleen Morrisroe
St Vincent's Hospital, Australia
Prof. Sandra Navarra
University Of Santo Tomas, Philippines
Prof. Fai Ng
Newcastle University, United Kingdom
Dr. Rachel Nelligan
The University Of Melbourne, Australia
Prof. Alexis Ogdie
University of Pennsylvania, United States
A/Prof. Kenji Oku
Department of Rheumatology and infectious Diseases, Kitasato University, Japan
Dr. Dana Orange
Rockefeller University, United States
Dr. Kade Paterson
Centre For Health, Exercise & Sports Medicine, He Unversity Of Melbourne, Australia
Dr. Jung Yoon Pyo
Yonsei University College Of Medicine, South Korea
Prof. Chaim Putterman
Bar Ilan Universtiy/Albert Einstein College Of Medicine, United States
A/Prof. Jasmin Raja
University Malaya Medical Centre, Malaysia
Philip Robinson
Australia
Prof. Kenneth Saag
University Of Alabama At Birmingham, United States
Dr. Ennaliza Salazar
Singapore General Hospital, Singapore
Dr. Anthony Michael Sammel
Prince Of Wales Hospital, Australia
Dr. Anindita Santosa
Division of Rheumatology, Changi General Hospital, Singapore
Dr Ho SO
Dr. Ho So
The Chinese University of Hong Kong, Hong Kong
Chang-Nam Son
Keimyung University School Of Medicine, South Korea
Prof. Dr. Georg Schett
Universitätsklinikum Erlangen, Department of Medicine 3, Germany
Prof. Chris Scott
University Of Cape Town, South Africa
Prof. Kichul Shin
Seoul Metropolitan Government-seoul National University Boramae Medical Center, South Korea
Prof. Lai-Shan Tam
The Chinese University Of Hong Kong, Hong Kong
Dr. Dhaval Tanna
Saurashtra Rheumatology Centre, India
Prof. Yoshiya Tanaka
University of Occupational and Environmental Health, Japan
Rene Toes
Dept. Of Rheumatology, Leiden University Medical Center, Netherlands
Dr. Lisa Traboco
St Luke's Medical Center - Global City, Philippines
Prof. Annette Van der van Mil
Leiden University Medical Center, Netherlands
Dr. Binit Vaidya
National Center For Rheumatic Diseases, Nepal
Prof. Chrong-Reen Wang
National Cheng Kung University Hospital And Medical College, Taiwan
Dr. Priscilla Wong
The Chinese University of Hong Kong, Hong Kong
Prof. Tian Xinping
Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, China
Prof. Guochun Wang
China-japan Friendship Hospital, China
MD Julie Yu
Philippine Rheumatology Association, Philippines
Prof. Raymond Yung
University of Michigan, United States
Prof. Kazuhiko Yamamoto
Riken Center for Integrative Medical Sciences, Japan
Prof. Zhuo-Li Zhang
Peking University First Hospital, China
Prof. Vahid Ziaee
Tehran University of Medical Sciences, Iran
Prof. Ali Zubairi
Aga Khan University, Pakistan
Translate »
Peter Nash

Prof. Peter Nash

 

Peter Nash is Professor in the School of Medicine at Griffith University, Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast. Prof Nash currently Chairs the ASMPOC, has Chaired the Professional Affairs Committee, the Therapeutics Committee , and the NHMRC musculoskeletal panels as well as serves on the Scientific Advisory Committee of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He remains on the International Steering Committee for GRAPPA. He is on the editorial board of Annals of the Rheumatic Diseases and RMD Open.

Prof. Nash and his group at the Rheumatology Research Unit have been involved in the pivotal registration clinical trials for all modern targeted biologic therapies and os-teoporosis therapies. He has published more than 230 peer-reviewed papers and 6 book chapters, and was recently recognised as Australian rheumatology leader for citations in the top 20 rheumatology journals over the last 5 years. Special interests include metabolic bone disease and novel therapeutics.

James Wei

Prof. James Wei

Taiwan

Professor Wei is currently Professor of Institute of Medicine, Chung Shan Medical University, Vice Superintendent and Director of Clinical Trial Center of Chung Shan Medical University Hospital, Taichung, Taiwan.

After his training in rheumatology and clinical immunology at Taichung and Kaohsiung Veterans General Hospital, Dr Wei undertook a fellowship at the Royal National Hospital for Rheumatic Diseases in Bath, UK, under Professor Andrei Calin. He pursued a research fellowship at the University of California, Los Angeles (UCLA), under Professor David Yu, investigating the pathogenesis of spondyloarthritis.

He has published 300+ articles in SCI journals, such as the NEJM, JAMA, Lancet, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, International Journal of Epidemiology and Rheumatology. He is currently the Editor-in-Chief of International Journal of Rheumatic Diseases and associate editor of the Frontiers in immunology and Frontiers in pharmacology.

His major interests are translational research in AS, clinical trials and big data epidemiological studies.

Prof. Debashish Danda

India

Prof. Annamaria Iagnocco

The University Of Turin, Italy

Annamaria Iagnocco is Professor of Rheumatology and Head of the Academic Rheumatology Centre at Turin University, Italy. She is EULAR President. She is former Head of the EULAR School of Rheumatology, former co-chair of the OMERACT Ultrasound Group, Chair of the Ultrasound Study Group of the Italian Society for Rheumatology, member of several working groups on ultrasound in RMDs and faculty teacher in the EULAR Sonography Courses. Her research interests in RMDs include education, arthritis, and imaging. She is a member of the Editorial Board of prestigious international journals and has authored more than 290 peer-reviewed publications.

Prof. Iain McInnes

United Kingdom

Iain McInnes is Vice Principal and Head of College of Medical Veterinary and Life Sciences, and Versus Arthritis Professor of Rheumatology in the University of Glasgow, Glasgow, United Kingdom. He is Director of the Versus Arthritis Centre of Excellence for Inflammatory Arthritis, lead from Glasgow that includes Universities of Oxford, Newcastle and Birmingham. He is immediate past chairman of the Foreum (Foundation for European Rheumatology Research) Scientific Committee, leads the European Roadmap programme that is defining the research agenda for European rheumatology for the next decade and is currently President of the European League Against Rheumatism (EULAR), the leading trans-national society for rheumatology across Europe.

Under these auspices he is creating the first pan-European Rheumatology Research Centre planning to launch in 2021. His work is mainly focused upon the understanding of the pathogenesis of immune mediated inflammatory diseases and encompasses basic discovery immunology through phase 1 and proof of concept experimental medicine clinical trials to leadership of pivotal phase 3 trials in the area of immune biology. His laboratory group performed original discovery work leading to the therapeutic targeting of a several inflammatory cytokines. More recently he has focused on the biology of myeloid cells in the pathogenesis of a number of immune diseases. He has published >400 peer-reviewed original and review articles with an h-index of >100. He is a Fellow of the Royal Society of Edinburgh and Fellow of the Academy of Medical Sciences. He was made CBE in 2019 by HM Queen Elizabeth II.

Prof. Eric Morand

Monash University School Of Clinical Sciences, Australia

Professor Morand graduated from Monash University, trained in rheumatology in Australia and the Royal National Hospital for Rheumatic Diseases, UK. His laboratory focusses on glucocorticoid-induced proteins in the immune system, and his clinical research on systemic lupus erythematosus. He founded the Asia Pacific Lupus Collaboration, which has focused on developing and validating new endpoints for SLE, including the Lupus Low Disease Activity State (LLDAS), now widely incorporated in clinical trials. He lead the TULIP2 trial of anifrolumab in SLE, resulting in regulatory approval of anifrolumab in the US, Japan, and EU.
Awards include the William E Paul Distinguished Innovator Award of the Lupus Research Alliance, New York, and the Parr Prize of the Australian Rheumatology Association.

Ranjeny Thomas

Prof. Ranjeny Thomas

Australia

Professor Thomas is Professor of Rheumatology at University of Queensland, Translational Research Institute, consultant Rheumatologist at Princess Alexandra Hospital, fellow of the Australian Academy of Health and Medical Sciences and member of the Order of Australia. She founded the Uniquest spin-off company Dendright. Her research seeks to understand autoimmune disease and restoration of immune tolerance. She developed and tested antigen-specific immunotherapy for Rheumatoid Arthritis, based on dendritic cell and liposome formats in two world first proof-of-concept trials. Her team is partnered with CSL in Sjogren’s syndrome immunotherapy, and she is progressing an antigen-specific immunotherapy for type 1 diabetes to clinical trials. She has contributed major insights into the role of the microbiome in spondyloarthropathy.

Prof. Kenneth Saag

University Of Alabama At Birmingham, United States

Dr. Saag is Professor of Medicine and holds the Jane Knight Lowe Endowed Chair in the Department of Medicine at the University of Alabama at Birmingham. At UAB he is also Director of the Division of Clinical Immunology and Rheumatology, Director of the Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center, and Director of the Center of Research Translation in Gout and Hyperuricemia.

Proud to have grown up in the diverse city of Evanston, Illinois, where he became an Eagle Scout and graduated third in his high school class of over 1,000 students, Dr. Saag was trained as a bioengineer at the University of Michigan, and received his MD from Northwestern University. As a medical resident at Evanston Hospital, he was recognized as Outstanding Intern of the Year and as a Chief Resident. While at the University of Iowa completing his fellowship in rheumatology, he simultaneously earned an MSc in epidemiology. At Iowa, he began his interest in and pursuit of clinical epidemiology and experimental therapeutics. Dr. Saag continued at the University of Iowa as an Assistant Professor until joining the University of Alabama at Birmingham, where he has been a practicing physician, educator, and research scientist since 1998.
Dr. Saag’s research has advanced the field of implementation science and disparities research in the areas of osteoporosis and gout. His recent work has focused on methods to implement evidence into practice using novel study designs. Using cohorts and other large databases, he has contributed to an understanding of comparative effectiveness and safety of drugs in rheumatoid arthritis, osteoporosis, and gout. He has authored more than 400 peer-reviewed manuscripts, including 3 original first-author articles in the New England Journal of Medicine on treatment of glucocorticoid-induced osteoporosis and on fracture prevention in women with osteoporosis. He has also authored more than 100 reviews, editorials, and book chapters, as well as the fi rst and second editions of the clinical handbook Diagnosis and Management of Osteoporosis. He has served on the editorial boards of Arthritis Care & Research, Annals of Internal Medicine, Archives of Internal Medicine, Bone, and other biomedical journals. As a research mentor, he has trained more than 20 postdoctoral fellows and junior faculty and has been principal investigator on several large program project grants at UAB. He directs the K and T training components for the UAB Center for Clinical and Translational Science. He served a term as a standing member on the NIH Neurologic Aging and Musculoskeletal Epidemiology (NAMES) study section and chaired the Arthritis Foundation Review Commit-tee, Clinical Outcomes and Therapeutics Study Section in the past.

Dr. Saag has been frequently recognized for his contributions to research and research training. Among the honors he has received are the UAB Max Cooper Research Award in 2005, the UAB Department of Medicine Research Award (fi rst place among professors) in 2012–2014, the 2017 UAB Dean’s Excellence Award for Mentor-ship, and the 2021 European Calcified Tissue Society Excellence in Research Award. He was elected to the Association of American Physicians in 2015. In 2013 the ACR honored him with its Excellence in Investigative Mentoring Award. He has been listed in Best Doctors annually since 1996. Through his research pursuits he has been a very frequent lecturer in all continents except Antarctica and has particularly enjoyed his collaborations and visiting professorships in Latin America. Past lectureships and plenary presentations have included visits to EULAR, PANLAR, APLAR, the European Calcified Tissue Society, the International Osteoporosis Foundation, the Australian and New Zealand Bone and Mineral Society, as well as rheumatology and metabolic bone disease societies in 30 countries.
Throughout his career, Dr. Saag has served actively in numerous medical professional and patient advocacy organizations, and has been particularly focused on developing practice guidelines and quality of care indicators. In 1998–2002 he was a member of the Institute of Medicine Committee on Identifying Effective Treatment for Gulf War Veterans’ Health Problems. In the early 2000s he served on the American Medical Association Osteoarthritis Performance Measures Physicians Workgroup, the National Center for Quality Assurance Musculoskeletal Workgroup, and the American Pain Society Low Back Pain Guidelines Committee. He was a member of the Ameri-can Society for Bone and Mineral Research Advocacy Committee in 2010–2013 and Program Co-Chair of the organization’s 2017 Meet-ing Planning Committee. He served on the National Osteoporosis Foundation Board of Trustees in 2008–2013 and was Vice-President of the organization in 2014–2016 and President in 2016–2018, during which time he also served as Co-Chair of the National Bone Health Alliance. He was a member of the American Gout Society Board of Directors in 2005–2020. In addition, he has served on the FDA Arthritis Drugs Advisory Committee and on numerous panels and work-ing groups of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, including delivering the keynote address on career journey for the NIAMS K-Trainees Forum in 2019.

A member of the American College of Rheumatology since 1992, Dr. Saag’s active involvement with the ACR began early in his career. He served on the Atypical Connective Tissue Diseases Classification Criteria Subcommittee and the Ad Hoc Committee to Revise Guidelines for Glucocorticoid-Induced Osteoporosis in 1998 and on the Professional Meetings Committee in 1998–2001. He was the senior author on 2 prior iterations of the ACR rheumatoid arthritis guidelines and he served as the American delegate to past EULAR rheumatoid arthritis guidelines. He also served as the senior author on the ACR COVID-19 treatment guidance document produced in 2020. He chaired the Summer Rheumatology Meeting Planning Committee in 2001 and was a member of the Educational Products Committee and the Academic Rheumatology Workforce Ad Hoc Committee in 2002. He served as Co-Chair of the ACR Quality Measures Subcommittee in 2007–2009, as Chair of the Committee on Quality of Care in 2009–2013, and as Chair of the Committee on Corporate Relations from 2018 to 2020. During his time on these committees he helped fashion new approaches to guideline development and advised the College on public–private partnerships during the start of the pandemic. Dr. Saag was appointed to the ACR Board of Directors in 2013 and to the ACR Finance Committee in 2016. He served as ACR Secretary in 2018–2020 and as President-Elect in 2020–2021.
Dr. Saag resides in Birmingham with his wife Leah. They have 3 daughters, Jenny (Christopher) Keshishian, Lauren (Yitzi) Peet-luk, and Stefanie Saag, who work as a certified nurse anesthetist at UAB, an epidemiologist faculty member at Vanderbilt University, and a social work student in Chicago, respectively. Dr. Saag and his wife enjoy international travel, hiking, eclectic food and wine, and in particular, spending time with their children, granddaughter Clara Keshishian, parents Jim Saag and Marlene Waller, extended family/friends throughout the country, and a large cadre of family dogs.

Prof. Dr. Georg Schett

Universitätsklinikum Erlangen, Department of Medicine 3, Germany

Georg Schett is professor of Internal Medicine and since 2006 head of the Department of Medicine 3 – Rheumatology and Immunology at Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg in Germany.

Professor Schett graduated from the University of Innsbruck (Austria) in 1994. After his dissertation from medical school, he worked as scientist at the Institute of BioMedical Aging Research of the Austrian Academy of Science in Innsbruck. Two years later, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003 he was promoted to professor of Internal Medicine. Before accepting his position as the chair of the Department of Internal Medicine 3 in Erlangen, he worked as a scientist in the United States of America for one year.

Georg Schett’s scientific work includes a broad spectrum of clinical and immunological issues, particularly the molecular basics of immune-inflammatory diseases. Initially, he investigated the immunology of atherosclerosis and focused on antibody-mediated endothelial cell damage. His research work led to the understanding of the phenomenon of LE-cells in 2007. He was awarded the renowned START Award in 2002 and established a research group for arthritis in Vienna. In 2008, he initiated in collaboration with colleagues the priority program IMMUNOBONE in Germany, funded by the German Research Foundation (DFG). IMMUNOBONE aims to elucidate the interactions between the skeletal and the immune systems. Since 2015, Prof. Schett has led the DFG collaborative research centre 1181 “Checkpoints for Resolution of Inflammation” in Erlangen. Additionally, he is spokesperson of the project METARTHROS, funded by the Federal Ministry of Education and Research, which investigates the impact of the metabolism on arthritis. In 2019, he received funding for the ERC-Synergy grant “4D+ nanoSCOPE Advancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscope” of which he is spokesperson. 4D nanoSCOPE aims to develop tools and techniques to permit time-resolved imaging and characterization of bone in three spatial dimensions (both in vitro and in vivo), thereby permitting monitoring of bone remodelling and revolutionizing the understanding of bone morphology and its function.

In 2021, Prof. Schett was appointed Vice President Research of Friedrich-Alexander University Erlangen-Nürnberg and also became a Leopoldina member of the National Academy of Sciences of Germany.

Professor Schett’s scientific work has been honored with several awards, including the Carol-Nachman Prize from Wiesbaden. He has published over 840 peer-reviewed papers.

Prof. Tsutomu Takeuchi

Japan
Present

Division of Rheumatology,
Department of Internal Medicine,
Keio University School of Medicine
Professor of Internal Medicine,
Chief of Rheumatology,
Vice dean, Keio University School of Medicine (October 1, 2011~Semptember 30, 2013)
General Director of Keio University Hospital (October 1, 2013~July 31, 2017)
Vice President of Keio University (August 1, 2017~present)

Prof. Lai-Shan Tam

The Chinese University Of Hong Kong, Hong Kong

Lai-Shan Tam, MD, is Division Head and a Professor at The Chinese University of Hong Kong. She was APLAR Vice President (2014-2016), chairperson of the APLAR International Affair Committee (2012-2021), CoE committee and the APLAR Academy co-ordinator (since 2021). Professor Tam was a member of the ACR International Task Force Subcommittee, EULAR Programme Committee (2016-2019), and EULAR honorary member (since 2019). She serves as the Associate Editor of International Journal of Rheumatic Disease and Arthritis Research and Therapy, and she is also the international advisory board member of the Lancet Rheumatology. She is the first author or co-author of over 240 articles published in major rheumatology journals. Her research interests include premature atherosclerosis and bone loss in patients with rheumatic diseases.

Dr Sakir Ahmed

Kalinga Institute Of Medical Sicences, India

Associate Professor; Clinician scientist and Editor; Interests include Digital Health, Fibrosis in rheumatic diseases and Pain pathways in rheumatic diseases.

Member of APLAR SIG on Digital Health and Telemedicine.
2019 APLAR Research Grant recipient

Prof. Sulaiman Al-Mayouf

King Faisal Specialist Hospital & Research Center, Saudi Arabia

Consultant of Pediatric Rheumatology at King Faisal Specialist Hospital & Research Center (KFSH-RC), Riyadh and Professor at Medical College, Alfaisal University.

Dr. Al-Mayouf served as a board- member of Saudi Society for Rheumatology.

He is the founder and member of Pediatric Rheumatology Arab Group (PRAG). He is the national coordinator for the Pediatric Rheumatology International Organization (PRINTO) and AutoInflammatory Disease Alliance (AIDA) Network.

Dr. Al-Mayouf authored numerous papers and reviews on pediatric rheumatology. In addition, he serves as a reviewer for several scientific journals. He is a frequent lecturing nationally and internationally in Pediatric Rheumatology.

Dr Elizabeth Ang

National University Hospital, Singapore

Elizabeth Ang is Senior Consultant, Paediatric Rheumatology in the Khoo Teck Puat-National University Children’s Medical Centre, National University Hospital, Singapore and Assistant Professor of the National University of Singapore Yong Loo Lin School of Medicine. She did her clinical Paediatric Rheumatology Fellowship in Boston Children’s Hospital/Harvard School of Medicine.

In her free time, she enjoys going to various countries in South East Asia to spread her love for Paediatric Rheumatology and to try and understand (and sometimes tackle, alongside local providers) the challenges of caring for children with rheumatic diseases there. She counts it her privilege to have made many friends and learnt much in the process. The COVID pandemic has restricted much of such travel in the last few years, which makes this upcoming congress especially precious to her.

A/Prof Thaschawee Arkachaisri

Kk Women’s And Children’s Hospital, Duke-nus Medical School, Singapore

Dr. Tash graduated from Mahidol University, Thailand in 1991. He then pursued his specialty and subspecialty training in the US and earned his American Board of Pediatrics, Allergy and Immunology and lastly, Pediatric Rheumatology at Cornell University prior to returning back to Thailand and established the first Pediatric Rheumatology department at Siriraj Hospital and Mahidol University in January 2001. He then moved back to the US and joined Children’s Hospital of Pittsburgh where he gained his research interest in scleroderma and established the first Pediatric Scleroderma clinical and research Program in 2006. Then, he developed the Localized Scleroderma Cutaneous Assessment Tool which is the well-accepted clinical assessment measures in Localized Scleroderma and has been well-accepted as the standard assessment worldwide. In 2009, he then moved back to Singapore to established its first Pediatric rheumatology clinical program and in 2011, the Asia-Pacific Pediatric Rheumatology Education and Research Network. Over the decades, he has published the epidemiologic and outcomes of children with rheumatic diseases in Singapore and Southeast Asia. He also actively involved in pediatric rheumatic diseases translational research in trying to better understand the underlying immune-mechanisms and predict outcomes. He is currently an Associate Professor, head and senior consultant at the Rheumatology and Immunology Department at KK Women’s and Children’s Hospital and Duke-NUS Medical School.

Prof. Tatsuya Atsumi

Hokkaido University, Japan

Tatsuya Atsumi, MD, PhD, Professor of Medicine in the Faculty of Medicine, Hokkaido University in Japan, is the head of the department of Rheumatology, Endocrinology and Nephrology.

After graduating at Hokkaido University in 1988, he has spent most of his carrier as a researcher in Sapporo, except 3 years in the Lupus Unit, St. Thomas’ hospital in London (1994-1997). His research interest includes clinical and basic aspect of systemic autoimmune diseases such as antiphospholipid syndrome, systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. He has over 600 research publications dealing with several aspects including rheumatology, in particular, with the pathogenesis, diagnosis and treatment of antiphospholipid syndrome.

Dr. Sunith Himantha Atukorale

Ministry Of Health, Sri Lanka

Dr Himantha Atukorale is a Consultant in Rheumatology & Rehabilitation working in the Ministry of Health, Sri Lanka. He is an International Fellow of American College of Rheumatology and Fellow of Royal College of Physicians of Edinburgh. Dr Himantha is also the webmaster and board member of APLAR Young Rheumatologists. He has been a founder interim board member of APLAR Young Rheumatologists. He is a visiting lecturer in Medical Faculty of Rajarata and also functions as a medical journalist. Dr Himantha had his training at several premier medical institutions in Sri Lanka and Rheumatology Unit at Dudley NHS Trust United Kingdom.

Dr. Elaine Au

Queen Mary Hospital, Hong Kong

Dr Elaine Au received her medical degree from the University of Hong Kong, and obtained her Physician fellowship in 2011, subspecialize in Rheumatology. In 2017, she completed her fellowship in Immunology under Pathology.

Dr Au currently is the consultant and Division Head of Clinical Immunology, Department of Pathology, in Queen Mary Hospital. She is also the chairman of the Immunology specialty board in the Hong Kong College of Pathologist. Dr Au is dedicated in immunology & allergy service development, both in clinical and laboratory service. She also actively participates in training and education. She is appointed as Honorary Clinical Associate Professor by both the Department of Medicine and the Department of Pathology of the University of Hong Kong.

A/Prof. Christine Bernal

University Of Santo Tomas, Philippines

Dr. Bernal is a pediatric rheumatologist who, after her residency training in pediatrics in UST Hospital, pursued her fellowship training in rheumatology in Baylor College of Medicine, Houston, Texas. While training abroad, she was a recipient of several prestigious awards including Drs. Ralph and Judith Feigin Resident Award of Excellence, American College of Rheumatology (ACR) outstanding fellow award and ACR Amgen Pediatric Rheumatology Research Award. Her research works on lupus, Kawasaki, polyarteritis nodosa and juvenile idiopathic arthritis has been published in international journals including Arthritis and Rheumatism, International Journal of Rheumatic Diseases and APLAR Journal of Rheumatology. She also authored chapters on lupus nephritis on Avner Pediatric Nephrology in 2021, on Disorders of Bones & Connective Tissues for Fundamentals of Pediatrics in 2014.and Juvenile idiopathic arthritis for Arthritis and Allied Conditions in 2005.

A graduate of UST Faculty of Medicine and Surgery, she now serves her alma mater as Associate Professor. At present, she is the section chief of Pediatric Rheumatology in UST Hospital and Cardinal Santos Medical Center; an active medical consultant in private tertiary hospitals in Metro Manila.

Andrew Briggs

Prof. Andrew Briggs

Curtin University, Australia

Andrew Briggs has combined a career of health policy and systems research; health policy/strategy; health consulting; and clinical practice. He currently works across these domains at a senior level. This unique portfolio provides him with skills and real-world insights into health systems strengthening from the clinical coalface through to system-level reform for musculoskeletal health. The focus of Professor Briggs’ research and policy work has centred on health systems strengthening, oriented around the delivery of high-value care for people with musculoskeletal health conditions and persistent pain across the lifecourse.. He holds a full Professor position at Curtin University, WA; is a clinical consultant to WorkSafe Victoria; and a senior consultant to the World Health Organization in musculoskeletal health and healthy ageing.

Matthew Buckland

Matthew Buckland

UCL GOSH-ICH, United Kingdom

I trained in medicine in London and encountered my first PID patient, a CGD patient, in the year I qualified. That early experience stayed with me and inspired me to become an immunologist involved in the long-term medical care of patients with immune disorders both primary and secondary to immunosuppressive therapy.

My research focus is in the epidemiology of immunodeficiency and in the mechanisms of immune reconstitution in congenital athymia following allogeneic thymus transplantation.
I am the current Chair of Immunodeficiency UK a charity that supports patients living with primary and secondary immune deficiencies.

Dr Cynthia Chan

Pamela Youde Nethersole Eastern Hospital, Hong Kong

Dr Chan obtained her Doctor of Medicine degree from the University of British Columbia in 2001. She was a member of the College of Family Physicians of Canada before pursuing further training in psychiatry in Hong Kong in 2006. She became a Fellow of the Hong Kong College of Psychiatrists in 2013. She has published original articles in international journals in the area of mental health and spondyloarthritis.

Prof. T M Chan

University of Hong Kong, Hong Kong

Daniel Tak Mao Chan obtained his MBBS, MD, and DSc degrees from the University of Hong Kong (HKU). He became Professor at the HKU Department of Medicine in 1999, then Chair Professor in 2005, Yu Chair of Nephrology in 2008, and Yu Chiu Kwong Chair of Medicine in 2011. He has been Chief of Nephrology of HKWC Hospitals since 2010.

His research themes include lupus nephritis and viral hepatitis in patients with kidney diseases. His seminal works established mycophenolate as standard-of-care for the treatment of lupus nephritis globally, and strategies to prevent HBV and HCV complications in patients with kidney disease, both resulting in significantly improved patient outcomes. Translational studies from his laboratory have increased the understanding of pathogenic mechanisms in renal inflammation and fibrosis. His publications have appeared in New England Journal of Medicine, Kidney International, Journal of American Society of Nephrology, Arthritis Rheumatology, Nature Review Nephrology, Gastroenterology, and Hepatology. He is Lead Author for the Lupus Nephritis chapter in the 2021 KDIGO Clinical Management Guideline for Glomerulonephritis, and author of chapters on hepatitis B management in kidney disease patients in UpToDate.

He has served as Associate Dean, Senate member, and University Selection & Promotion Committee member at HKU, and is currently Member of the HKU Council. He also served as President of Asian Pacific Society of Nephrology (APSN), President of Hong Kong Society of Transplantation, Executive Committee member of Asian Society of Transplantation, HK West Cluster Hospitals Department of Medicine Chief of Clinical Service, Chairman of Hong Kong Hospital Authority Coordinating Committee in Internal Medicine, and Council member of International Society of Nephrology (ISN). Since 2016 he is Vice-President and Chairman of Education & Accreditation Committee of Hong Kong College of Physicians. He is serving on the Biology & Medicine panel of Hong Kong Research Grants Council Joint Research Scheme, and as grant reviewer for research funding institutes locally and overseas. He established the first (and only) ABO-incompatible kidney transplant program in Hong Kong at Queen Mary Hospital in 2017. He received the HKU Outstanding Researcher Award in 2006, and the APSN Kenzo Oshima Award in 2014.

Dr Shirley Chiu Wai Chan

University Of Hong Kong, Hong Kong

Dr Shirley Chan is a specialist in Rheumatology with special interests in spondyloarthritis and other autoimmune rheuamtic diseases. Dr Chan obtained her Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Hong Kong (HKU). She then received her specialty training in Queen Mary Hospital. She is currenlty working as a Clinical Assistant Professor in HKU. One of her research interests covers the role of imaging in spondyloarthritis, including novel MRI sequence and the potential application of artificial intelligence in image interpretation.

Sze Ngai Jeffrey Chau

Prof. Dr. Georg Schett

Grappa Prp, Hong Kong

GRAPPA Patient Research Partner, Hong Kong, China.
Founding Chairperson of Hong Kong Psoriatic Arthritis Association

Xanthe Chua

Xanthe Chua

Tan Tock Seng Hospital, Singapore

Ms Xanthe Chua is a Rheumatology Advanced Practice Nurse (APN) at the Tan Tock Seng Hospital (TTSH). Prior to this appointment, she was a Rheumatology Nurse Clinician, providing education and support to patients with rheumatic diseases. In 2014, she played a pivotal role in setting up the Rheumatology Nurse-led Arthritis Clinic in TTSH. She was previously invited to conduct training to Malaysia nurses, imparting them with counselling skills. She had also partnered Ms Susan Oliver in 2018, conducting arthritis counselling workshop for local nurses and allied health professionals.

APN Chua completed her Bachelor’s degree in Nursing (University of Sydney) Subsequently, she undertook the Advanced Rheumatology Course under the American College of Rheumatology and a Master’s degree in Nursing (National University of Singapore). She is currently the appointed hospital lead by MOH Singapore, overseeing the APN Internship Program.

Assoc. Prof. Sumapa Chaiamnuay

Phramongkutklao Hospital, Thailand

Associate Professor Sumapa Chaiamnuay graduated from the faculty of Medicine, Chulalongkorn University, Thailand. She completed Internal Medicine residency training from Albert Einstein Medical Center, Philadelphia, and Rheumatology fellowship training from The University of Alabama at Birmingham. She served as the past secretary of the Thai Osteoporosis Foundation. Currently, she is the Chief of Thai Osteoporosis Foundation Public Relations, and the chief of the Rheumatic Disease unit at Phramongkutklao hospital. Her research interest is osteoporosis in rheumatic disease patients, and she’s on the working committee for the Thai Osteoporosis Clinical Practice Guideline 2021.

Ernest Choy

Prof. Ernest Choy

United Kingdom

Professor Ernest Choy is Head of Rheumatology and Translational Research at the Division of Infection and Immunity and Director of the Cardiff Regional Experimental Arthritis Treatment and Evaluation (CREATE) Centre at Cardiff University School of Medicine, Cardiff, Wales, UK. He is also Honorary Consultant Rheumatologist at University Hospital of Wales and Clinical Lead of the Welsh Arthritis Research Network (WARN). Prof Choy chaired the EULAR Taskforce on developing recommendations for management and classification criteria for fibromyalgia in 2007 and currently a member of the EULAR Quality of Care Committee. Prof Choy has served as clinical expert to the National Institute for Clinical Excellence in the UK and many pharmaceutical companies. He has published widely on treatments for rheumatic diseases in major medical journals such as the New England Journal of Medicine and The Lancet.

Dr Ho Yin Chung

Hong Kong Society Of Rheumatology, Hong Kong

Chung Ho Yin is a medical consultant in Chiron Medical. He received his doctor of medicine and specialist training in Hong Kong and was a clinical assistant professor at the University of Hong Kong and an Associate Consultant at Queen Mary Hospital. He is a council member of the Hong Kong Society of Rheumatology, fellow of the Royal College of Physician (Edinburgh), and member of the special interest group (SIG) in spondyloarthritis of the Hong Kong Society of Rheumatology (HKSR) and Asia Pacific League of Associations for Rheumatology (APLAR). He is also the associate editor of the Journal of Clinical Rheumatology and Immunology and International Journal of Rheumatic Diseases. His areas of interest include application of magnetic resonance imaging (MRI) in axial spondyloarthritis. His research articles have been published in numerous international journals including an Editor’s Choice in the Annals of the Rheumatic Diseases. He was awarded outstanding free paper bronze prize in the 9th Guangdong-Hong Kong Rheumatology Seminar 2014, best free paper award, International Conference of Chinese Rheumatologists 2018, and best abstract in APLAR 2018 and 2021.

Prof. Francesco Ciccia

University Della Campania L. Vanvitelli, Italy

Prof. Francesco Ciccia is a MD and PhD, specialized in Internal Medicine and Rheumatology for many years involved in research on the immunological basis of sytemic autoimmune diseases. His training took place between the University of Palermo and the King’s College of London. Currently Dr. Ciccia holds the position of Full Professor of Rheumatology and head of the section of Clinical and Experimental Rheumatology at the University of Naples. The research of Professor. Ciccia is focused on the study of the innate and adaptive immune mechanisms involved in the pathogenesis of Ankylosing Spondylitis, psoriatic arthritis, Sjogren’s syndrome and giant cell vasculitis.

Dr Thorlene Egerton

The University Of Melbourne, Australia

Dr Thorlene Egerton is a senior lecturer with the Physiotherapy Department, and a senior research fellow with the Centre for Health, Exercise & Sports Medicine. Her current research interests are in bridging the evidence-practice gap in osteoarthritis management. She is particularly interested in novel models of care and education strategies to support effective self-management and behaviour change.

Thorlene coordinates the post-graduate masters of Clinical Rehabilitation. She teaches Health Behaviour Change, Evaluation of Rehabilitation Practice and Physical Activity & Exercise subjects as well as supervising the master students’ Research Project subject.

She has published 53 articles in peer-reviewed journals and produced a short patient education video explaining knee osteoarthritis with a novel empowerment discourse

Prof Dirk Elewaut

Vib Center For Inflammation Research; Ghent University, Belgium

Dirk Elewaut is a Full Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology and Immunology at Ghent University Hospital, Ghent, Belgium, a European Alliance of Associations for Rheumatology (EULAR) and Federation of Clinical Immunology Societies (FOCIS) centre of excellence. He received his medical degree at Ghent University in 1991 and his PhD in 1997 at the same institution. Following his postdoctoral research at the University of California San Diego and the La Jolla Institute for Allergy and Immunology, CA, USA, he joined the faculty of the Department of Rheumatology at Ghent University Hospital in 2001.

He has published more than 300 scientific publications in leading scientific journals and is Principal Investigator of the Unit of Molecular Immunology and Inflammation of the VIB Center for Inflammation Research at Ghent University. Currently, he serves as Chair of the EULAR Research Center and as a member of the editorial boards of several leading rheumatology journals. He has received several awards including the 2020 Carol Nachman Award. His research interests are centred around translational aspects of immune regulation to combat inflammatory arthritis and associated joint damage, with a special focus on the link between gut and joint disease in spondyloarthritis

Dr. Ivan Foeldvari

Hamburger Zentrum Für Kinder- Und Jugendrheumatologie, Germany
Academic Training

1979 Medical School J.W. Goethe University Frankfurt/M, Germany.
1980 Medical School Semmelweiss University Budapest, Hungary
1986 MD with “”summa cum laude”” Semmelweiss University, Budapest, Hungary
1995 End of a 2 year Paediatric Rheumatology Fellowship, with Prof. Dr. R.E. Petty, Children’s Hospital, University of British Columbia, Vancouver, Canada
1996 End of the Paediatric Residency (Germany)
1996 Head of the Paediatric Rheumatology Unit at the University Children´s Hospital in Hamburg
2000- Head of the Hamburger Zentrum für Kinder- und Jugendrheumatologie, at the Klinikum Eilbek, Hamburg
2007- Head of the Kompetenz – Zentrum für Sklerodermie und Uveitis im Kindes- und Jugendalter, at the Klinikum Eilbek, Hamburg
2011 Faculty at the Asklepius Campus Hamburg of the Semmelweiss Medical University, Budapest, Hungary”

Prof. Sumaira Farman

National Hospital & Medical Center; Central Park Medical College; FJMU; Arthritis Care Foundation, Pakistan
Qualifications:

MRCP (UK); Specialty Certificate Examination (SCE) Rheumatology (UK); International Fellow of American College of Physicians (FACP) & Rheumatology (FACR); Fellow Royal College of Physicians (FRCP) London; GradCertPRheum (Australia).

Primarily an adult rheumatologist, she interned in pediatric rheumatology, Kansas University Medical Centre, USA through an ACP International Fellowship; and acquired the Graduate Certificate in Paediatric Rheumatology (GradCertPRheum) from the University of Western Australia.

Based in Lahore, Pakistan, she is Professor and Head of Rheumatology Department National Hospital & Medical Centre, Visiting Faculty and Chair of the Paediatric Rheumatology program at Central Park Medical College.
She is Associate Editor IJRD.
She is Focal Representative Global Paediatric MSK Task Force, and Convener APLAR Paediatric Rheumatology SIG.

She is Immediate Past President, Pakistan Society for Rheumatology Co-Founder & Co-Chairperson Arthritis Care Foundation, Lahore.

Dr Shunsuke Furuta

Chiba University Hospital, Japan
Education:
2008 Ph.D. (Dr. of Medical Science), Chiba University 2000 M.D. Chiba University School of Medicine
Professional Training and Employment:
2015-presentAssociate Professor in Department of Allergy and Clinical Immunology, Chiba University Hospital 2013-2015 Department of Allergy and Clinical Immunology, Chiba University Hospital 2012-2013 Research Fellow in Lupus and Vasculitis Clinic, Cambridge University Hospital, Cambridge, UK 2008-2011 Department of Allergy and Clinical Immunology, Asahi General Hospital 2004-2008Department of Allergy and Clinical Immunology, Chiba University Hospital 2003-2004 Internal Medicine, Yokohama Rousai Hospital 2001-2003Internal Medicine, Numazu City Hospital 2000-2001Resident in Internal Medicine, Chiba University Hospital
Certification:
2010 Japan College of Rheumatology-board Certified Rheumatologist

Dr. Takahisa Gono

Department Of Allergy And Rheumatology, Nippon Medical School Graduate School Of Medicine, Japan
Education & Training

UNDERGRADUATE/GRADUATE:
2004, Ph.D, Shinshu University Graduate School
1992-1998, Yamanashi University, Yamanashi, Japan, M.D. 1998

POSTGRADUATE:
2003-2004, Nagano National Hospital, Nagano, Japan, Medical Doctor in Internal Medicine (Rheumatology)
2000-2001, Iida Municipal Hospital, Nagano, Japan, Medical Doctor in Internal Medicine (Neurology)
1999-2000, Fujimi Kogen Hospital, Nagano, Japan, Resident in Internal Medicine
1998-1999, Shinshu University, Nagano, Japan, Resident in Internal Medicine

SPECIALITY CERTIFICATION
2002 The Japanese Society of Internal Medicine
2006 The Japanese Society of Neurology
2006 The Japanese College of Rheumatology

AWARD
2012 Young Investigator’s Award of the Japanese Society of Rheumatology
2013 Young Investigator’s Award of the Japanese Society of Internal Medicine

Appointments & Positions

ACADEMIC:
2016-Present: Associate Professor, Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine
2015-2016: Associate Professor, Department of Rheumatology, Saitama Medical Center, Jichi Medical University
2014-2015: Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University
2007-2014: Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University
2004-2007: Assistant Professor, Third department of Internal Medicine (Rheumatology and Neurology), Shinshu University
2001-2003: Research fellow, Third department of Internal Medicine (Rheumatology and Neurology), Shinshu University

SCIENTIFIC SOCIETY:
Councilor of The Japanese College of Rheumatology
Councilor of The Japanese Society of Clinical Immunology
Editorial Board, BioMed Research International Journal

Jon Giles

Dr. Jon Giles

Columbia University, Vagelos College Of Physicians & Surgeons, United States

Dr Giles is currently a tenured Associate Professor of Medicine in the Division of Rheumatology at Columbia University. Dr. Giles’s research interests are centered primarily within the inflammatory arthritides. Recent projects center around understanding how inflammation affects adipose tissue and muscle in people with rheumatoid arthritis and psoriatic arthritis, and their subsequent effects on health outcomes. Other current and past research involve the investigation of accelerated atherosclerosis and myocardial dysfunction in rheumatoid arthritis patients, understanding the determinants of rheumatoid arthritis-associated interstitial lung disease. He is the recipient of grant support from the National Institutes of Health, the Arthritis Foundation, the Rheumatology Research Foundation, and the Arthritis National Research Foundation.

Latika Gupta

India

Dr Gupta is a rheumatologist, clinical immunologist, and clinician scientist working as Assistant Professor at SGPGI, a tertiary care teaching hospital in Lucknow, India. She currently serves as the Social Media Editor for several Rheumatology journals and is the APLAR (Asia Pacific League of Associations for Rheumatology) Young Rheumatology Webmaster and Board Member from India.

She is a dedicated researcher (136 publications, H index 12, I index 19) with an interest in myositis, spondyloarthritis and digital health. She recently founded Myositis India, a patient support group for patients with this disease.

Besides enjoying medical teaching Dr Gupta enjoys amateur photography, poetry, and photo painting.

Prof Rebecca Grainger

University of Otago, New Zealand

Rebecca is an academic rheumatologist who is passionate about patient-focused care and engaging with colleagues in primary and secondary care to provide the highest quality collaborative care for people with arthritis. A University of Otago medical graduate, she undertook rheumatology training in Melbourne and her PhD examined inflammatory mechanisms in gout. Rebecca’s clinical work focuses on the assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout and scleroderma. Rebecca’s academic interests include outcome measures, non-pharmacological management of musculoskeletal disease, use of information technology solutions to optimise care for people with chronic rheumatic diseases and medical education.

Sofia Grigoriadou

Sofia Grigoriadou

Barts Health Nhs Trust, United Kingdom

Sofia Grigoriadou (MD, PhD, FRCP, FRCPath) is a Consultant Immunologist at Barts Health NHS Trust, the largest hospital in UK and one of the largest centres for primary immunodeficiency disorders in the country.

She has a special interest in autoimmune diseases and B cell biology. She has been involved in the care of patients with primary immunodeficiencies for over 20 years.

Dr. Laniyati Hamijoyo

University Of Padjadjaran, Indonesia

Laniyati Hamijoyo is a Rheumatology consultant at Internal medicine Department, Faculty of Medicine University of Padjadjaran Bandung, Indonesia. Currently she actively serves as member of several medical organisations, such as co-opted members of APLAR (2021-present), member of Asia Pacific Lupus Collaboration (APLC) (2013-present), and Lupus SIG of APLAR (2017-present), and Indonesian Rheumatology Association (IRA) (2010-present). She actively involves in several national or international clinical trials and has done several studies, been author, co-author, reviewer of several journals and books. Her main interest is in the field of Lupus, Spondyloarthritis and Gout.

Muhammad Haroon

Prof. Muhammad Haroon

Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Pakistan

Muhammad Haroon graduated in Medicine from King Edward Medical College, Lahore. He completed his basic specialist training from Royal College of Physicians of Ireland through rotations in different University Hospitals before embarking on higher specialist training in Rheumatology. He subsequently completed his dual fellowships in Rheumatology and Internal Medicine through Irish Committee on Higher Medical Training of Royal College of Physicians.

He undertook a period of clinical research at St Vincent’s University Hospital Dublin under the supervision of Prof Oliver FitzGerald, and also with Prof Robert Winchester at Columbia University Medical Centre, New York, USA, and was subsequently awarded the PhD degree. He has developed a special interest in clinical and genetic research in Psoriatic Arthritis and Spondyloarthropathies.

He has also developed special interest in sports & Exercise Medicine. He has earned Master’s Degree in Sports & Exercise Medicine from University College Cork Ireland, and he also holds a fellowship with the faculty of Sports & Exercise Medicine, Royal College of Surgeons in Ireland. He has the experience of running Sports Clinic.

He has authored so far, >100 publications in international scientific Journals as a first author, and has presented nearly 100 abstracts as first author in different national and international rheumatology meetings.

He also worked as a Staff Physician in Rheumatology Department, Bone and Joint Unit, St Vincent’s University Hospital Dublin. From 2013-2018, he worked as a Consultant Rheumatologist in the Department of Medicine at University Hospital Kerry and also served as a Clinical Senior Lecturer at University College Cork. He also served as a Chair of the department of Medicine at this University Hospital. He was the department of medicine research lead at University Hospital Kerry. He has established the National Psoriatic Arthritis Registry of Ireland, which he served as the national lead. He has been involved in a number of International clinical research projects, and was also on national advisory board panels. He has been a recipient of various national and international awards.

He has recently returned back to Pakistan with a passion to provide state of the art care for rheumatology patients and also to turn research into better arthritis care. Currently he is heading an academic rheumatology department, and is actively engaged in teaching and training undergraduate and postgraduate students. He is supervising clinical and genetic research from his department and he has successfully managed to establish The Rheumatic Diseases Registry of Pakistan. From his current post in Pakistan, he has managed to publish his research in the top most scientific rheumatology Journals, such as Annals of Rheumatic Diseases and Arthritis & Rheumatology.

Prof. Masayoshi Harigai

Tokyo Women’s Medical University, Japan

Masayoshi Harigai, MD, PhD is Professor and Head of Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan. He served as Professor of Department of Pharmacovigilance at Tokyo Medical and Dental University between 2007 and 2015 and has been installed in the present position in 2019. Professor Harigai is the principal investigator of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis, clinical trial of tocilizumab for ANCA-associated vasculitis, and 2020 Japanese Clinical Practice Guidelines for the Management of Rheumatoid Arthritis. He has been serving as a board member of Japan College of Rheumatology since 2018.

Dr. Tze Kwan, Carmen Ho

Queen Mary Hospital, Hong Kong

Dr Carmen Tze-Kwan HO
MBBS, FHKCP (HK), FHKAM (Med), FRCP (Edinburg, London)
Consultant of Queen Mary Hospital/ Tung Wah Hospital/ Grantham Hospital
Honorary Clinical Associate Professor, LKS Faculty of Medicine, The University of Hong Kong

Carmen graduated from The University of Hong Kong in 1992, subsequently became Consultant Rheumatologist of Queen Mary Hospital, Tung Wah Hospital and Grantham Hospital. She was the past President of The Hong Kong Society of Rheumatology from 2014-2018.

Dr. Kei Ikeda

Chiba University Hospital, Japan

Dr Kei Ikeda graduated from Chiba University School of Medicine, Japan in 1997. After his rheumatology training, he engaged himself in basic research at Chiba University Graduate School of Medicine, Japan and finished his PhD programme in 2004. Dr Ikeda learned musculoskeletal ultrasound and clinical research at Tan Tock Seng Hospital, Singapore from 2005 to 2006 and at Leeds University, UK from 2006 to 2007. He is now working as an assistant professor/ senior lecturer in Department of Allergy and Clinical Immunology, Chiba University Hospital, Japan.
Dr Ikeda is a practicing rheumatologist and a researcher. His current research interest is imaging, biomarkers, and the pathophysiology of rheumatic/autoimmune diseases.

Kanon Jatuworapruk

Dr Kanon Jatuworapruk

Thammasat University, Thailand

Dr Kanon Jatuworapruk is a rheumatologist at the Faculty of Medicine, Thammasat University, Thailand. He is passionate about providing excellent care for people with crystal-associated arthritis, especially gout, as well as deepening the knowledge of rheumatic diseases in Asia-Pacific region. His recent researches focus on the epidemiology, prediction and impact of gout flare.

Dr Jatuworapruk is a medical graduate from Chiang Mai University and has completed his PhD from the University of Otago, where he developed clinical prediction rule for gout flare in hospitalized patients. He is a member of G-CAN (Gout, Hyperuricemia and Crystal-Associated Disease Network), APLAR crystal-induced arthritis special interest group, APLAR young rheumatologist group, the 2020 EULAR-APLAR exchange program and Thai Rheumatism Association research committee.

Dr Matthew Jiang

Western Health, Australia

Matthew Jiang is a rheumatologist based in Melbourne, Australia who works in public and private practice, including the Osteoarthritis Hip and Knee Service at St Vincent’s Hospital.

Prof Alireza Khabbazi

Connective Tissue Diseases Research Center, Tabriz University Of Medical Sciences, Tabriz, Iran

I was born in 1966 in Tabriz. I completed my high school education at Ferdowsi High School in Tabriz. I started studying medicine at Tabriz University of Medical Sciences in 1985. I studied specialty in internal medicine at Tabriz University of Medical Sciences from 1997 to 2001 and Subspecialty in rheumatology at Tehran University of Medical Sciences from 2003 to 2005. In 2005, I employed as an Assistant Professor in Internal Medicine group at medical faculty of Tabriz University of Medical Sciences. I became a professor in 2017. My positions are Research deputy in Internal Medicine group, manager of Vasculitis Registry of Connective Tissue Disease Research Center and Head of the Connective Tissue Disease Research Center. My research field is Behcet’s disease, vasculitis and palindromic rheumatism. I have 115 articles in English indexed in Scopus.

Dinesh Khanna

University of Michigan, United States

Dinesh Khanna, MD, MSc, is Professor of Medicine and Director, University of Michigan Scleroderma Program. He holds the Frederick G.L. Huetwell Professorship in Rheumatology. Dr. Khanna has published over 450 peer-reviewed articles and book chapters. He is the Principal Investigator on National Institutes of Health and industry-sponsored clinical studies. He is the coordinating PI on investigator-initiated and pharmacetucal sponsored clinical trials in scleroderma. His current research focus on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He received the prestigious 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology.

Prof. Masataka Kuwana

Nippon Medical School, Japan

Dr. Masataka Kuwana is a professor of rheumatology and a director of scleroderma/myositis center of excellence at Nippon Medical School in Tokyo, Japan. Dr. Kuwana has published more than 430 peer-reviewed scientific articles and written more than 10 book chapters. He is listed as an editorial board member of 7 peer-reviewed journals, and serves as an Editor-in-Chief of Modern Rheumatology and the Journal of Scleroderma and Related Disorders. Dr. Kuwana is considered an internationally recognized leading expert in systemic sclerosis, myositis, pulmonary hypertension, interstitial lung disease, and autoimmunity.

Prof Mitsumasa Kishimoto

Kyorin university school of medicine, Japan

Mitsumasa Kishimoto is currently serves as an associate professor at Kyorin University School of Medicine.

After completing the first training in Japan, he completed an Internal Medicine Residency program at the University of Hawaii, and a Rheumatology Fellowship program at New York University. In 2006 he took the role of Program Director of the Department of Rheumatology at the Kameda Medical Center, then from 2009 to 2019, clinical program director in St Lukes International hospital before moving on to accept his current positions in 2019.

Dr Kishimoto was certified by the American Board of Internal Medicine and Rheumatology and received an ACR Distinguished Fellow Award in 2006.

He was a Steering committee member in the ‘APLAR guidelines for management of rheumatoid arthritis and is currently SIG member in Spondyloarthritis. He also serves as a Steering committee member in JCR guidelines for management of RA, PsA, and SpA, and Epidemiological survey of SAPHO syndrome in Japan.

He is a GRAPPA and ASAS member, and Japan’s Principal Investigators for the ‘ASAS-Comospa and perSpA’ studies.

Dr Kishimoto is an author of over 110 scientific publications including NEJM and Lancet articles.

Ms. Kwok Suet Kei

Hospital Authority, Hong Kong

Ms Kwok obtained Master of Nursing degree at the University of Hong Kong in 2004 and Graduate Certificate in Rheumatology Practice in the UK in 2009.  

She is now the advanced practice nurse-in-charge of Rheumatology and Clinical Immunology Centre of Grantham Hospital. She is also the Chairman of education committee and executive member of the Hong Kong Arthritis and Rheumatism Foundation.

She was the program development committee member of the Hong Kong rheumatology nursing curriculum and core working group member of the Asia-Pacific Initiative for Rheumatology Nurse Education since 2016.  

Ms Kwok was the author of randomized control trial on nurse-led consultation for patients with rheumatoid arthritis; co-author of published articles on SpA, Rheumatology Nurse education and development in Asia Pacific. She has ongoing research collaboration with EULAR champion countries on recommendations for patient education in inflammatory arthritis.

A/Prof Yohei Kirino

Yokohama City University, Japan

Graduated from Yokohama City University School of Medicine in 2001, and completed the doctoral program at the same university’s Graduate School of Medicine in 2006. After a fellowship in internal medicine and rheumatology, I joined the US NIH/NHGRI Dr. Kastner Lab as a visiting fellow. I am currently working at Yokohama City University Hospital as an adult rheumatologist. My interests include adult autoinflammatory diseases such as Behcet’s disease, VEXAS syndrome, and adult Still’s disease.

Dr. Laura Lewandowski

Head, Lupus Genomics and Global Disparities Unit, NIAMS, NIH, United States

Dr. Laura Lewandowski completed pediatric residency training at the University of Massachusetts Medical Center and went on to serve as a chief resident in pediatrics. During her chief resident year, she developed a specialty track for pediatric residents in Global Health, including curriculum design and coordination of international rotations. She completed a combined four-year pediatric rheumatology/ global health fellowship at Duke University Medical Center, during which she characterized a pediatric lupus patient cohort in South Africa. She holds a Masters in Global Health from Duke University. During her fellowship, she collaborated with Dr. Chris Scott to establish a registry of pediatric lupus patients that continues to grow and is now the largest cohort in sub-Saharan Africa. She was awarded a Fogarty Global Health Fellowship and a Lupus Foundation Early Career award for her work with pediatric lupus patients in South Africa.

In 2015, she joined the NIAMS under Dr. Mariana Kaplan as a Lawrence Shulman Scholar in Translational Medicine. She currently holds the position of Assistant Clinical Investigator and Head of the Lupus Genomics and Global Health Disparities Unit at NIAMS, NIH. Her current research interests include clinical and translational research in pediatric systemic lupus erythematosus (SLE), with a focus on genetic drivers of severe disease and inflammation in varied cohorts around the world.

Dr. Lewandowski has held several leadership positions including serving as co-chair Childhood Arthritis and Rheumatic Diseases Research Alliance (CARRA) Lupus Nephritis workgroup, co-chair of the CARRA Lupus Genetics Workgroup, chair of the CARRA Translation Research and Technology Committee Data Management, and chair CARRA Annual Meeting Planning Committee. She is a member of Early Career Investigator Committee within the American College of Rheumatology; whose aim is to develop the next generation of researchers in the rheumatology field. In addition, she has mentored students and trainees in North America and South Africa in rheumatology research. She is a USA representative on the Paediatric Musculoskeletal Task Force. She has published many articles on lupus in Africa and the challenges to rheumatology clinical care, education and practice in less resourced countries. She has lectured nationally and internationally on the genetics of pediatric lupus in global populations and global rheumatology clinical care and research.

Dr. Philip Li

The University of Hong Kong, Hong Kong

Dr Philip Li is a Specialist in Immunology & Allergy and Clinical Assistant Professor under the Department of Medicine at the University of Hong Kong.

Dr Li has led the development of the in-patient drug allergy and immunology service as well as establishing the Immunology Clinics at Queen Mary and Grantham Hospitals. Dr Li is also a council member of the Hong Kong Institute of Allergy, executive committee member of the Hong Kong Allergy Association, and the Asia Pacific Association of Allergy Asthma and Clinical Immunology’s Drug Allergy Committee.

Dr Li has special interests in anaphylaxis, drug hypersensitivity and immunodeficiency. He conducted the region’s foremost drug allergy studies and now leads Hong Kong’s territory-wide drug allergy de-labelling initiative. He has published over 70 peer-reviewed articles in the fields of allergy, immunology and autoimmunity; and serves on the Editorial Boards of Frontiers in Allergy and Journal of Clinical Rheumatology and Immunology.